Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Molecular Diagnostics

Image: The blood-based assay captures circulating chromatin, cell-free DNA fragments that are largely inaccessible through standard laboratory methods (image credit: Shuttertstock)

Blood-Based Assay Enables Noninvasive Monitoring of Sarcoma Immunotherapy Response

A new cfDNA assay captures immune, stromal and tumor signals to monitor immunotherapy response and resistance in sarcoma More...
03 Jun 2026
Image: Image: Findings showed that TP53 mutations correlate with lung cancer prognosis and may help guide therapy selection(image credit: Adobe Stock)

Tumor Mutation Marker Helps Refine Lung Cancer Prognosis and Guide Therapy Selection

New data show TP53 mutations in lung cancer predict poorer prognosis and guide selection between EGFR therapy and chemotherapy. More...
02 Jun 2026
PATHFINDER 2 Study: Screen Detected Cancers (Photo courtesy of GRAIL)

Multi-Cancer Test Boosts Detection When Added to Standard Screening

PATHFINDER 2 study findings show that GRAIL’s Galleri MCED test increased cancer detection 6.5-fold when added to recommended cancer screening. More...
02 Jun 2026
Image: Findings show that MRD‑guided intervention demonstrated the potential to delay or possibly prevent leukemic relapse (image credit: Shutterstock)

Blood-Based MRD Monitoring Supports Relapse Prevention in Leukemia

New long-term data show MRD-triggered therapy may delay or prevent relapse in MDS and AML. More...
01 Jun 2026
Image: The Decipher Prostate test can guide treatment decisions in metastatic prostate cancer (Photo courtesy of Veracyte)

Genomic Test Predicts Chemotherapy Benefit in Metastatic Prostate Cancer

New data show a genomic test predicts which metastatic prostate cancer patients benefit from triplet therapy. More...
01 Jun 2026
Image: New findings shows that specific blood proteins are altered long before multiple sclerosis diagnosis, pointing to a potential approach for pre-symptomatic risk assessment (image credit: Adobe Stock)

Blood Protein Markers Flag Multiple Sclerosis Risk Years Before Diagnosis

Researchers identify plasma proteins altered years before MS, supporting pre-symptomatic risk stratification and prognosis. More...
01 Jun 2026
Image: NHS-Galleri Trial: Percent difference in Stage IV cancers (Photo courtesy of GRAIL)

MCED Blood Test Reduces Stage IV Cancer Diagnoses in NHS Trial

GRAIL reported NHS-Galleri trial findings at ASCO 2026 showing fewer stage IV diagnoses despite missing the combined stage III–IV endpoint. More...
31 May 2026
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Automated Coagulation Analyzer
Hemolumi H6


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.